Immunotherapy for hepatocellular carcinoma: The challenge of biomarker studies

^*此作品的通信作者

研究成果: Letter › 同行評審

3 引文斯高帕斯（Scopus）

原文	English
頁（從 - 到）	121-122
頁數	2
期刊	Journal of the Chinese Medical Association
卷	84
發行號	2
DOIs	https://doi.org/10.1097/JCMA.0000000000000458
出版狀態	Published - 2月 2021

存取文件

@article{b9a5694a24cd4afc99e13f864fdcadf6,

title = "Immunotherapy for hepatocellular carcinoma: The challenge of biomarker studies",

author = "Lee, {I. Cheng}",

year = "2021",

month = feb,

doi = "10.1097/JCMA.0000000000000458",

language = "English",

volume = "84",

pages = "121--122",

journal = "Journal of the Chinese Medical Association",

issn = "1726-4901",

publisher = "Elsevier Taiwan LLC",

number = "2",

}

TY - JOUR

T1 - Immunotherapy for hepatocellular carcinoma

T2 - The challenge of biomarker studies

AU - Lee, I. Cheng

PY - 2021/2

Y1 - 2021/2

UR - http://www.scopus.com/inward/record.url?scp=85102018429&partnerID=8YFLogxK

U2 - 10.1097/JCMA.0000000000000458

DO - 10.1097/JCMA.0000000000000458

M3 - Letter

C2 - 33177399

AN - SCOPUS:85102018429

SN - 1726-4901

VL - 84

SP - 121

EP - 122

JO - Journal of the Chinese Medical Association

JF - Journal of the Chinese Medical Association

IS - 2

ER -